Technical Analysis for PFE - Pfizer, Inc.

Grade Last Price % Change Price Change
grade F 35.72 -0.36% -0.13
PFE closed down 0.36 percent on Friday, February 21, 2020, on 1.45 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical PFE trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Gilligan's Island Buy Setup Bullish Swing Setup -0.36%
Down 3 Days in a Row Weakness -0.36%
Down 4 Days in a Row Weakness -0.36%
Down 5 Days in a Row Weakness -0.36%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. Its Primary Care segment offers human prescription pharmaceutical products primarily prescribed by primary-care physicians for Alzheimer's disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation therapeutic and disease areas. The company's Specialty Care and Oncology segment provides human prescription pharmaceutical products for anti-infectives, endocrine disorders, hemophilia, inflammation, ophthalmology, pulmonary arterial hypertension, specialty neuroscience, and vaccines, as well as oncology and oncology-related illnesses. Its Established Products and Emerging Markets segment offers human prescription pharmaceutical products that have lost patent protection or marketing exclusivity in certain countries and/or regions, as well as that are sold in emerging markets, including Asia, Latin America, the Middle East, Eastern Europe, Africa, Turkey, and Central Europe. The company's Animal Health segment offers products and services to prevent and treat disease in livestock and companion animals, including anti-infectives, vaccines, parasiticides, medicinal feed additives, other pharmaceutical products, and other non-pharmaceutical products. Its Consumer Healthcare segment provides non-prescription products in therapeutic categories, such as dietary supplements, pain management, respiratory, and personal care. The company sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. has a strategic collaboration with CytomX Therapeutics, Inc. to develop and commercialize Multiple Probody drug conjugates in oncology. The company was founded in 1849 and is headquartered in New York, New York.
Health Biopharmaceutical Pharmaceutical Industry Pain Disease Medication Pharmaceutical Products Inflammation Neuroscience Alzheimer's Disease Pain Management Cnx Nifty Dietary Supplements Pulmonary Arterial Hypertension Major Depressive Disorder Hemophilia Anti Infectives Pfizer Erectile Dysfunction Glaxosmithkline Livestock Producers Cardiovascular Endocrine Disorders Lupin Limited Non Pharmaceutical Products

Is PFE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 44.5613
52 Week Low 33.97
Average Volume 21,191,744
200-Day Moving Average 38.83
50-Day Moving Average 38.61
20-Day Moving Average 37.54
10-Day Moving Average 36.93
Average True Range 0.62
ADX 28.82
+DI 12.38
-DI 36.78
Chandelier Exit (Long, 3 ATRs ) 39.11
Chandelier Exit (Short, 3 ATRs ) 37.27
Upper Bollinger Band 39.79
Lower Bollinger Band 35.29
Percent B (%b) 0.1
BandWidth 11.97
MACD Line -0.78
MACD Signal Line -0.56
MACD Histogram -0.2174
Fundamentals Value
Market Cap 212.44 Billion
Num Shares 5.95 Billion
EPS 1.37
Price-to-Earnings (P/E) Ratio 26.07
Price-to-Sales 4.06
Price-to-Book 3.64
PEG Ratio 2.40
Dividend 1.28
Dividend Yield 3.58%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 36.16
Resistance 3 (R3) 36.14 35.98 36.08
Resistance 2 (R2) 35.98 35.87 35.99 36.06
Resistance 1 (R1) 35.85 35.80 35.77 35.87 36.03
Pivot Point 35.69 35.69 35.65 35.70 35.69
Support 1 (S1) 35.56 35.58 35.48 35.58 35.41
Support 2 (S2) 35.40 35.51 35.41 35.38
Support 3 (S3) 35.27 35.40 35.36
Support 4 (S4) 35.29